Literature DB >> 22801977

An investigation of the mechanisms of hydrogen sulfide-induced vasorelaxation in rat middle cerebral arteries.

E Streeter1, J Hart, E Badoer.   

Abstract

Hydrogen sulfide (H(2)S) is an endogenous mediator with peripheral vasorelaxant effects; however, the mechanism of H(2)S-induced vasorelaxation in cerebral blood vessels has not been extensively studied. Vasorelaxation studies were performed on middle cerebral arteries from male Sprague Dawley rats using wire myography. Immunofluorescence staining was used to detect the presence of the H(2)S-producing enzyme cystathionine-γ-lyase (CSE). CSE was present in the endothelium and smooth muscle of middle cerebral arteries. The CSE substrate, L-cysteine, induced vasorelaxation that was sensitive to the CSE inhibitor DL-propargylglycine. This relaxation was independent of endothelium, suggesting that H(2)S was produced in the vascular smooth muscle. The H(2)S donor, sodium hydrogen sulfide (NaHS; 0.1-3.0 mM) produced concentration-dependent relaxation, which was unaffected by endothelium removal. Nifedipine (3 μM) significantly reduced the maximum relaxation elicited by NaHS. Inhibiting potassium (K(+)) conductance with 50 mM K(+) significantly attenuated NaHS-induced relaxation, however, selective blockers of ATP sensitive (K(ATP)), calcium sensitive (K(Ca)), voltage dependent (K(V)), or inward rectifier (K(ir)) channels alone or in combination did not affect the response to NaHS. 4,4-diisothiocyanatostilbene-2,2-disulfonic acid (DIDS; 300 μM) caused a significant rightward shift of the NaHS concentration-response curve, but this effect could not be explained by inhibition of Cl(-) channels or Cl(-)/HCO (3)(-) exchange, as selective blockade of these mechanisms had no effect. These findings suggest endogenous H(2)S can regulate cerebral vascular function. The H(2)S-mediated relaxation of middle cerebral arteries is DIDS sensitive and partly mediated by inhibition of L-type calcium channels, with an additional contribution by K channels but not K(ATP), K(Ca), K(V), or K(ir) subtypes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22801977     DOI: 10.1007/s00210-012-0779-2

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  52 in total

1.  Hydrogen sulfide as an endothelium-derived hyperpolarizing factor in rodent mesenteric arteries.

Authors:  Gillian Edwards; Michel Félétou; Arthur H Weston
Journal:  Circ Res       Date:  2012-01-06       Impact factor: 17.367

2.  Vasoactivity of the gasotransmitters hydrogen sulfide and carbon monoxide in the chicken ductus arteriosus.

Authors:  Saskia van der Sterren; Pamela Kleikers; Luc J I Zimmermann; Eduardo Villamor
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-03       Impact factor: 3.619

3.  The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide.

Authors:  R Hosoki; N Matsuki; H Kimura
Journal:  Biochem Biophys Res Commun       Date:  1997-08-28       Impact factor: 3.575

4.  Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor.

Authors:  G M Rubanyi; P M Vanhoutte
Journal:  Am J Physiol       Date:  1986-05

Review 5.  Hydrogen sulfide: its production, release and functions.

Authors:  Hideo Kimura
Journal:  Amino Acids       Date:  2010-02-27       Impact factor: 3.520

6.  H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms.

Authors:  Weimin Zhao; Rui Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-08       Impact factor: 4.733

7.  Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide.

Authors:  Norihiro Shibuya; Yoshinori Mikami; Yuka Kimura; Noriyuki Nagahara; Hideo Kimura
Journal:  J Biochem       Date:  2009-07-15       Impact factor: 3.387

8.  Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes.

Authors:  Ying-Gang Sun; Yin-Xiang Cao; Wen-Wei Wang; Shan-Feng Ma; Tai Yao; Yi-Chun Zhu
Journal:  Cardiovasc Res       Date:  2008-06-04       Impact factor: 10.787

9.  Hydrogen sulphide regulates intracellular pH in vascular smooth muscle cells.

Authors:  Shiau Wei Lee; Yvonne Cheng; Philip K Moore; Jin-Song Bian
Journal:  Biochem Biophys Res Commun       Date:  2007-05-21       Impact factor: 3.575

Review 10.  Role of sulfur-containing gaseous substances in the cardiovascular system.

Authors:  Joanne L Hart
Journal:  Front Biosci (Elite Ed)       Date:  2011-01-01
View more
  16 in total

1.  Hydrogen Sulfide Targets the Cys320/Cys529 Motif in Kv4.2 to Inhibit the Ito Potassium Channels in Cardiomyocytes and Regularizes Fatal Arrhythmia in Myocardial Infarction.

Authors:  Shan-Feng Ma; Yan Luo; Ying-Jiong Ding; Ying Chen; Shi-Xin Pu; Hang-Jing Wu; Zhong-Feng Wang; Bei-Bei Tao; Wen-Wei Wang; Yi-Chun Zhu
Journal:  Antioxid Redox Signal       Date:  2015-03-31       Impact factor: 8.401

2.  Chloride channels mediate sodium sulphide-induced relaxation in rat uteri.

Authors:  Ana Mijušković; Aleksandra Nikolić Kokić; Zorana Oreščanin Dušić; Marija Slavić; Mihajlo B Spasić; Duško Blagojević
Journal:  Br J Pharmacol       Date:  2015-05-15       Impact factor: 8.739

3.  H2S relaxes isolated human airway smooth muscle cells via the sarcolemmal K(ATP) channel.

Authors:  Robert Fitzgerald; Breann DeSantiago; Danielle Y Lee; Guangdong Yang; Jae Yeon Kim; D Brian Foster; Yee Chan-Li; Maureen R Horton; Reynold A Panettieri; Rui Wang; Steven S An
Journal:  Biochem Biophys Res Commun       Date:  2014-03-12       Impact factor: 3.575

4.  Hydrogen sulfide treatment reduces blood pressure and oxidative stress in angiotensin II-induced hypertensive mice.

Authors:  Mohammad R Al-Magableh; Barbara K Kemp-Harper; Joanne L Hart
Journal:  Hypertens Res       Date:  2014-08-07       Impact factor: 3.872

5.  Hydrogen sulfide protects endothelial nitric oxide function under conditions of acute oxidative stress in vitro.

Authors:  Mohammad R Al-Magableh; Barbara K Kemp-Harper; Hooi H Ng; Alyson A Miller; Joanne L Hart
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-09-26       Impact factor: 3.000

Review 6.  Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases.

Authors:  Guoliang Meng; Yan Ma; Liping Xie; Albert Ferro; Yong Ji
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

7.  Contribution of hydrogen sulfide to the control of coronary blood flow.

Authors:  Eli D Casalini; Adam G Goodwill; Meredith K Owen; Steven P Moberly; Zachary C Berwick; Johnathan D Tune
Journal:  Microcirculation       Date:  2014-02       Impact factor: 2.628

8.  Vasorelaxation elicited by endogenous and exogenous hydrogen sulfide in mouse mesenteric arteries.

Authors:  Joanne L Hart
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-11-12       Impact factor: 3.000

9.  Hydrogen sulfide as a vasculoprotective factor.

Authors:  Eloise Streeter; Hooi H Ng; Joanne L Hart
Journal:  Med Gas Res       Date:  2013-04-29

10.  TRPP2 associates with STIM1 to regulate cerebral vasoconstriction and enhance high salt intake-induced hypertensive cerebrovascular spasm.

Authors:  Wan Jiang; Li Ye; Yuexin Yang; Pingping Wang; Wen Pan; Juan Du; Bing Shen; Kai Wang
Journal:  Hypertens Res       Date:  2019-09-20       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.